DSY.PA
$18.11
Dassault Systèmes SE provides software solutions and services worldwide.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Dassault Systèmes SE provides software solutions and services worldwide. The company offers 3D modeling applications, such as SOLIDWORKS, CATIA, GEOVIA, and BIOVIA; social and collaborative applications, including 3DEXCITE, CENTRIC PLM, and ENOVIA; a...
Recent News
Assessing Dassault Systèmes (ENXTPA:DSY) Valuation After New MODS Inc. Modular Housing Partnership
Dassault Systèmes (ENXTPA:DSY) drew fresh investor attention after MODS Inc. agreed to use its virtual twin and 3DEXPERIENCE platform across modular housing projects, including a committed pipeline of €500 million equivalent in construction work. See our latest analysis for Dassault Systèmes. Despite the MODS and Medidata announcements highlighting fresh use cases for its platforms, Dassault Systèmes’ 1-month share price return of 4.08% sits against a much weaker year-to-date share price...
Assessing Dassault Systèmes (ENXTPA:DSY) After A 53% One-Year Share Price Drop
If you are wondering whether Dassault Systèmes shares are starting to look interesting at current levels, this article walks through what the numbers are actually saying about value. The stock last closed at €18.18, with returns of 0.8% over the past week, a 21.6% decline over 30 days, a 22.3% decline year to date, and a 53.3% decline over the past year. These moves come as investors keep a close eye on Dassault Systèmes as a large European software name, where sentiment can swing quickly...
Dassault Systèmes Deepens AI Role In Drug Development And Manufacturing
Medidata, a Dassault Systèmes (ENXTPA:DSY) brand, received top innovation ratings for its AI driven clinical trial solutions and a Luminary designation for its role in FDA novel drug approvals. Medidata’s AI platforms are used across a large share of FDA novel drug approvals, supporting trial efficiencies and digital workflows in clinical research. Dassault Systèmes expanded its healthcare footprint through a new collaboration between Medidata and CRIO focused on clinical data...
Dassault and Airbus are Turning FCAS Into a Public Spat
Dassault CEO Eric Trappier says the next-generation fighter needs one clear leader, and he is done pretending the fight is about engineering
Dassault and Airbus Turn Europe’s Next Fighter Jet Into a Public Spat
Dassault CEO Eric Trappier says the next-generation fighter needs one clear leader, and he is done pretending the fight is about engineering